55,146 Shares in Varex Imaging $VREX Purchased by Fox Run Management L.L.C.

Fox Run Management L.L.C. acquired a new stake in shares of Varex Imaging (NASDAQ:VREX) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 55,146 shares of the company’s stock, valued at approximately $684,000. Fox Run Management L.L.C. owned approximately 0.13% of Varex Imaging as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. The Manufacturers Life Insurance Company lifted its stake in shares of Varex Imaging by 10.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock valued at $133,000 after purchasing an additional 1,442 shares during the period. LSV Asset Management raised its holdings in Varex Imaging by 0.5% in the second quarter. LSV Asset Management now owns 328,610 shares of the company’s stock worth $2,849,000 after purchasing an additional 1,631 shares in the last quarter. BNP Paribas Financial Markets lifted its position in Varex Imaging by 18.5% during the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after buying an additional 2,036 shares during the period. State of Alaska Department of Revenue purchased a new position in Varex Imaging during the third quarter valued at $27,000. Finally, Nebula Research & Development LLC boosted its holdings in shares of Varex Imaging by 11.0% during the 2nd quarter. Nebula Research & Development LLC now owns 22,795 shares of the company’s stock valued at $198,000 after buying an additional 2,250 shares in the last quarter.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Jefferies Financial Group reiterated a “hold” rating and issued a $14.50 price target on shares of Varex Imaging in a research note on Monday, February 2nd. Wall Street Zen upgraded shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a report on Saturday. B. Riley Financial reiterated a “buy” rating on shares of Varex Imaging in a report on Thursday, February 12th. Oppenheimer dropped their price target on Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 19th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Varex Imaging in a research report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Varex Imaging has a consensus rating of “Hold” and a consensus price target of $16.17.

Varex Imaging Stock Performance

Shares of VREX opened at $13.17 on Friday. The company has a market cap of $551.82 million, a price-to-earnings ratio of -8.03 and a beta of 0.90. The business’s fifty day simple moving average is $13.30 and its two-hundred day simple moving average is $12.21. Varex Imaging has a 12 month low of $6.76 and a 12 month high of $14.56. The company has a current ratio of 3.89, a quick ratio of 1.87 and a debt-to-equity ratio of 0.75.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.05. Varex Imaging had a positive return on equity of 8.43% and a negative net margin of 7.92%.The firm had revenue of $209.60 million for the quarter, compared to the consensus estimate of $207.83 million. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. Research analysts anticipate that Varex Imaging will post 0.53 earnings per share for the current fiscal year.

Varex Imaging Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.